Tensions Flare at the American Diabetes Association as Federal Health Initiatives Target Screen Time and Tick-Borne Allergies
admin The American Diabetes Association (ADA) is currently navigating a period of intense internal and external...
Health
ADA CEO Addresses Controversy Over Conference Disruptions and Federal Research Funding Challenges
The American Diabetes Association (ADA) is currently navigating one of the most turbulent periods in...
Internal Review Clears American Diabetes Association of Wrongdoing in Member Ejections, Sparking Renewed Debate Over Scientific Dissent
The American Diabetes Association (ADA) has officially concluded an internal investigation into the controversial removal...
5 burning questions on Trump’s latest deals with drugmakers
At the heart of the controversy is the "Most Favored Nation" (MFN) concept, a policy...
The Lindsay Clancy Trial and the Precarious Future of Reproductive Psychiatry
The legal proceedings surrounding the tragedy of Lindsay Clancy have reached a tense impasse as...
House votes to temporarily block Trump plan to politicize federal grants
The crux of the legislative friction lies in a proposed revision to the "Uniform Guidance"—the...
The Invisible Workforce: Why the Trump Administration’s Nutrition Revolution Faces a Dietitian Shortage Crisis.
In the halls of the Department of Health and Human Services (HHS) in Washington, a...
Will House delay Trump plan to politicize NIH grants?
The "Most Favored Nation" (MFN) model, a policy concept that has traversed a tumultuous legal...
GLP-1 drugs are almost single-handedly forcing employers to reconsider workers’ health care
The core of this legal dispute often centers on the 340B program, a federal initiative...
Trump Administration Expands Drug Pricing Pledges with Nine New Pharmaceutical Partners to Curb Costs and Bolster Strategic Reserves.
In a move that significantly broadens the White House’s ongoing efforts to overhaul the American...
